Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type

Condition:   Irritable Bowel Syndrome of Diarrhea Type (IBS-D) Interventions:   Drug: OPS-2071;   Drug: placebo Sponsor:   Otsuka Beijing Research Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials